{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:47:24Z","timestamp":1785552444215,"version":"3.56.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EYO116119"],"award-info":[{"award-number":["EYO116119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K99EY027013"],"award-info":[{"award-number":["1K99EY027013"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Priority Grant"},{"name":"Davimos Family Endowment for Excellence in Science"},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["0815022E"],"award-info":[{"award-number":["0815022E"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00109-018-1683-0","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T19:29:13Z","timestamp":1534188553000},"page":"1107-1118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization"],"prefix":"10.1007","volume":"96","author":[{"given":"Manas R.","family":"Biswal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-3093","authenticated-orcid":false,"given":"Howard M.","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Kathleen","family":"Dorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred S.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet C.","family":"Blanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Munoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564\u2013572","journal-title":"Arch Ophthalmol"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1001\/jamaophthalmol.2016.2383","volume":"134","author":"S Vitale","year":"2016","unstructured":"Vitale S, Clemons TE, Agron E et al (2016) Evaluating the validity of the age-related eye disease study grading scale for age-related macular degeneration: AREDS2 report 10. JAMA Ophthalmol 134:1041\u20131047","journal-title":"JAMA Ophthalmol"},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","volume":"106","author":"JS Sunness","year":"1999","unstructured":"Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, Barron Y, Bergman A (1999) Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 106:1768\u20131779","journal-title":"Ophthalmology"},{"key":"1683_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","volume":"142","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa K, Kannan R, Hinton DR (2016) Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res 142:19\u201325","journal-title":"Exp Eye Res"},{"key":"1683_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00417-009-1133-3","volume":"247","author":"CM Sheridan","year":"2009","unstructured":"Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D (2009) Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 247:1361\u20131367","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1683_CR6","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.ophtha.2016.04.056","volume":"123","author":"PA Campochiaro","year":"2016","unstructured":"Campochiaro PA, Aiello LP, Rosenfeld PJ (2016) Anti-vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside. Ophthalmology 123:S78\u2013S88","journal-title":"Ophthalmology"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/17425247.2016.1213240","volume":"14","author":"VM Villegas","year":"2017","unstructured":"Villegas VM, Aranguren LA, Kovach JL, Schwartz SG, Flynn HW Jr (2017) Current advances in the treatment of neovascular age-related macular degeneration. Expert Opin Drug Deliv 14:273\u2013282","journal-title":"Expert Opin Drug Deliv"},{"key":"1683_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/archopht.130.1.124","volume":"130","author":"T Williams","year":"2012","unstructured":"Williams T, Reeves BC, Foss AJ, Fell G (2012) Risks of adverse events with therapies for age-related macular degeneration: a response. Arch Ophthalmol 130:124\u2013125 author reply 125-126","journal-title":"Arch Ophthalmol"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMicm1005605","volume":"364","author":"DF Martin","year":"2011","unstructured":"Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897\u20131908","journal-title":"N Engl J Med"},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367","journal-title":"Am J Pathol"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","volume":"9","author":"GL Semenza","year":"2014","unstructured":"Semenza GL (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9:47\u201371","journal-title":"Annu Rev Pathol"},{"key":"1683_CR12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V94.5.1561","volume":"94","author":"T Hellwig-Burgel","year":"1999","unstructured":"Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W (1999) Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94:1561\u20131567","journal-title":"Blood"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ki.1997.77","volume":"51","author":"GL Semenza","year":"1997","unstructured":"Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, Leung S, Roe R, Wiener C, Yu A (1997) Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51:553\u2013555","journal-title":"Kidney Int"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","volume":"91","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro PA (2013) Ocular neovascularization. J Mol Med (Berl) 91:311\u2013321","journal-title":"J Mol Med (Berl)"},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jconrel.2013.10.008","volume":"172","author":"T Iwase","year":"2013","unstructured":"Iwase T, Fu J, Yoshida T, Muramatsu D, Miki A, Hashida N, Lu L, Oveson B, Lima e Silva R, Seidel C, Yang M, Connelly S, Shen J, Han B, Wu M, Semenza GL, Hanes J, Campochiaro PA (2013) Sustained delivery of a HIF-1 antagonist for ocular neovascularization. J Control Release 172:625\u2013633","journal-title":"J Control Release"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1167\/iovs.11-8936","volume":"53","author":"M Lin","year":"2012","unstructured":"Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, le YZ, Ge J, Ma JX (2012) Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Vis Sci 53:6197\u20136206","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/gt.2009.158","volume":"17","author":"C Zhang","year":"2010","unstructured":"Zhang C, Wang YS, Wu H et al (2010) Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly (D, L-lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model. Gene Ther 17:338\u2013351","journal-title":"Gene Ther"},{"key":"1683_CR18","first-page":"471","volume":"14","author":"CJ Dougherty","year":"2008","unstructured":"Dougherty CJ, Smith GW, Dorey CK, Prentice HM, Webster KA, Blanks JC (2008) Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vector. Mol Vis 14:471\u2013480","journal-title":"Mol Vis"},{"key":"1683_CR19","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.1167\/iovs.10-6835","volume":"52","author":"HM Prentice","year":"2011","unstructured":"Prentice HM, Biswal MR, Dorey CK, Blanks JC (2011) Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease. Invest Ophthalmol Vis Sci 52:8562\u20138570","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O'Reilly","year":"1997","unstructured":"O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277\u2013285","journal-title":"Cell"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)61697-5","volume":"159","author":"K Mori","year":"2001","unstructured":"Mori K, Ando A, Gehlbach P, Nesbitt D, Takahashi K, Goldsteen D, Penn M, Chen CT, Mori K, Melia M, Phipps S, Moffat D, Brazzell K, Liau G, Dixon KH, Campochiaro PA (2001) Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol 159:313\u2013320","journal-title":"Am J Pathol"},{"key":"1683_CR22","doi-asserted-by":"publisher","first-page":"8044","DOI":"10.1167\/iovs.14-13932","volume":"55","author":"MR Biswal","year":"2014","unstructured":"Biswal MR, Prentice HM, Dorey CK, Blanks JC (2014) A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization. Invest Ophthalmol Vis Sci 55:8044\u20138053","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1006\/mthe.2002.0702","volume":"6","author":"A Auricchio","year":"2002","unstructured":"Auricchio A, Behling KC, Maguire AM, O'Connor EE, Bennett J, Wilson JM, Tolentino MJ (2002) Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents. Mol Ther 6:490\u2013494","journal-title":"Mol Ther"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/sj.gt.3302769","volume":"13","author":"KS Balaggan","year":"2006","unstructured":"Balaggan KS, Binley K, Esapa M, MacLaren RE, Iqball S, Duran Y, Pearson RA, Kan O, Barker SE, Smith AJ, Bainbridge JWB, Naylor S, Ali RR (2006) EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. Gene Ther 13:1153\u20131165","journal-title":"Gene Ther"},{"key":"1683_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/hum.2016.117","volume":"28","author":"PA Campochiaro","year":"2017","unstructured":"Campochiaro PA, Lauer AK, Sohn EH, Mir TA, Naylor S, Anderton MC, Kelleher M, Harrop R, Ellis S, Mitrophanous KA (2017) Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study. Hum Gene Ther 28:99\u2013111","journal-title":"Hum Gene Ther"},{"key":"1683_CR26","doi-asserted-by":"publisher","first-page":"31274","DOI":"10.1074\/jbc.M003441200","volume":"275","author":"A Boulanger","year":"2000","unstructured":"Boulanger A, Liu S, Henningsgaard AA, Yu S, Redmond TM (2000) The upstream region of the Rpe65 gene confers retinal pigment epithelium-specific expression in vivo and in vitro and contains critical octamer and E-box binding sites. J Biol Chem 275:31274\u201331282","journal-title":"J Biol Chem"},{"key":"1683_CR27","first-page":"131","volume":"7","author":"AM Timmers","year":"2001","unstructured":"Timmers AM, Zhang H, Squitieri A, Gonzalez-Pola C (2001) Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol Vis 7:131\u2013137","journal-title":"Mol Vis"},{"key":"1683_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.exer.2015.07.022","volume":"140","author":"MR Biswal","year":"2015","unstructured":"Biswal MR, Ahmed CM, Ildefonso CJ, Han P, Li H, Jivanji H, Mao H, Lewin AS (2015) Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress. Exp Eye Res 140:94\u2013105","journal-title":"Exp Eye Res"},{"key":"1683_CR29","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","volume":"153","author":"T Tobe","year":"1998","unstructured":"Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641\u20131646","journal-title":"Am J Pathol"},{"key":"1683_CR30","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez MLA, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM, Rakic JM, Noel A (2013) Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc 8:2197\u20132211","journal-title":"Nat Protoc"},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1167\/iovs.14-14633","volume":"55","author":"H Mao","year":"2014","unstructured":"Mao H, Seo SJ, Biswal MR et al (2014) Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration. Invest Ophthalmol Vis Sci 55:4613\u20134627","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/jop.2015.0049","volume":"31","author":"RS Sulaiman","year":"2015","unstructured":"Sulaiman RS, Quigley J, Qi X, O\u2019Hare MN, Grant MB, Boulton ME, Corson TW (2015) A simple optical coherence tomography quantification method for choroidal neovascularization. J Ocul Pharmacol Ther 31:447\u2013454","journal-title":"J Ocul Pharmacol Ther"},{"key":"1683_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.exer.2010.01.011","volume":"90","author":"F Kong","year":"2010","unstructured":"Kong F, Li W, Li X, Zheng Q, Dai X, Zhou X, Boye SL, Hauswirth WW, Qu J, Pang JJ (2010) Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse. Exp Eye Res 90:546\u2013554","journal-title":"Exp Eye Res"},{"key":"1683_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jgm.1053","volume":"9","author":"M Khoury","year":"2007","unstructured":"Khoury M, Adriaansen J, Vervoordeldonk MJ et al (2007) Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis. J Gene Med 9:596\u2013604","journal-title":"J Gene Med"},{"key":"1683_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/sj.gt.3301642","volume":"9","author":"M Roy","year":"2002","unstructured":"Roy M, Hom JJ, Sapolsky RM (2002) HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption. Gene Ther 9:214\u2013219","journal-title":"Gene Ther"},{"key":"1683_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.healun.2009.05.014","volume":"28","author":"J Zhao","year":"2009","unstructured":"Zhao J, Bolton EM, Bradley JA, Lever AM (2009) Lentiviral-mediated overexpression of Bcl-xL protects primary endothelial cells from ischemia\/reperfusion injury-induced apoptosis. J Heart Lung Transplant 28:936\u2013943","journal-title":"J Heart Lung Transplant"},{"key":"1683_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/02713680490517872","volume":"29","author":"F Schuettauf","year":"2004","unstructured":"Schuettauf F, Vorwerk C, Naskar R, Orlin A, Quinto K, Zurakowski D, Dejneka NS, Klein RL, Meyer EM, Bennett J (2004) Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity. Curr Eye Res 29:379\u2013386","journal-title":"Curr Eye Res"},{"key":"1683_CR38","first-page":"93","volume":"10","author":"WC Wu","year":"2004","unstructured":"Wu WC, Lai CC, Chen SL, Sun MH, Xiao X, Chen TL, Tsai RJ, Kuo SW, Tsao YP (2004) GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol Vis 10:93\u2013102","journal-title":"Mol Vis"},{"key":"1683_CR39","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1096\/fj.02-0824fje","volume":"17","author":"K Takahashi","year":"2003","unstructured":"Takahashi K, Saishin Y, Silva RL et al (2003) Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J 17:896\u2013898","journal-title":"FASEB J"},{"key":"1683_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1084\/jem.20022027","volume":"198","author":"S Ishida","year":"2003","unstructured":"Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D\u2019Amore PA, Shima DT, Adamis AP (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198:483\u2013489","journal-title":"J Exp Med"},{"key":"1683_CR41","doi-asserted-by":"publisher","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","volume":"3","author":"M Saint-Geniez","year":"2008","unstructured":"Saint-Geniez M, Maharaj AS, Walshe TE et al (2008) Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3:e3554","journal-title":"PLoS One"},{"key":"1683_CR42","doi-asserted-by":"publisher","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","volume":"290","author":"T Kamba","year":"2006","unstructured":"Kamba T, Tam BY, Hashizume H et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560\u2013H576","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1683_CR43","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1073\/pnas.0905010106","volume":"106","author":"M Saint-Geniez","year":"2009","unstructured":"Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D\u2019Amore PA (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106:18751\u201318756","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1683_CR44","first-page":"338","volume":"3","author":"M Berry","year":"2001","unstructured":"Berry M, Barrett L, Seymour L, Baird A, Logan A (2001) Gene therapy for central nervous system repair. Curr Opin Mol Ther 3:338\u2013349","journal-title":"Curr Opin Mol Ther"},{"key":"1683_CR45","doi-asserted-by":"publisher","first-page":"19064","DOI":"10.1074\/jbc.M309881200","volume":"279","author":"N Esumi","year":"2004","unstructured":"Esumi N, Oshima Y, Li Y, Campochiaro PA, Zack DJ (2004) Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation. J Biol Chem 279:19064\u201319073","journal-title":"J Biol Chem"},{"key":"1683_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejpb.2015.01.009","volume":"95","author":"C Schon","year":"2015","unstructured":"Schon C, Biel M, Michalakis S (2015) Retinal gene delivery by adeno-associated virus (AAV) vectors: strategies and applications. Eur J Pharm Biopharm 95:343\u2013352","journal-title":"Eur J Pharm Biopharm"},{"key":"1683_CR47","first-page":"637","volume":"39","author":"A Nicoletti","year":"1998","unstructured":"Nicoletti A, Kawase K, Thompson DA (1998) Promoter analysis of RPE65, the gene encoding a 61-kDa retinal pigment epithelium-specific protein. Invest Ophthalmol Vis Sci 39:637\u2013644","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/hum.2008.046","volume":"20","author":"S Kachi","year":"2009","unstructured":"Kachi S, Binley K, Yokoi K, Umeda N, Akiyama H, Muramatu D, Iqball S, Kan O, Naylor S, Campochiaro PA (2009) Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization. Hum Gene Ther 20:31\u201339","journal-title":"Hum Gene Ther"},{"key":"1683_CR49","doi-asserted-by":"publisher","first-page":"e96494","DOI":"10.1371\/journal.pone.0096494","volume":"9","author":"A Berger","year":"2014","unstructured":"Berger A, Cavallero S, Dominguez E, Barbe P, Simonutti M, Sahel JA, Sennlaub F, Raoul W, Paques M, Bemelmans AP (2014) Spectral-domain optical coherence tomography of the rodent eye: highlighting layers of the outer retina using signal averaging and comparison with histology. PLoS One 9:e96494","journal-title":"PLoS One"},{"key":"1683_CR50","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.gt.3301001","volume":"6","author":"K Binley","year":"1999","unstructured":"Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S (1999) An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer. Gene Ther 6:1721\u20131727","journal-title":"Gene Ther"},{"key":"1683_CR51","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/sj.gt.3301945","volume":"10","author":"JW Bainbridge","year":"2003","unstructured":"Bainbridge JW, Mistry A, Binley K et al (2003) Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization. Gene Ther 10:1049\u20131054","journal-title":"Gene Ther"},{"key":"1683_CR52","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1126\/science.7871435","volume":"267","author":"CJ Schoenherr","year":"1995","unstructured":"Schoenherr CJ, Anderson DJ (1995) The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267:1360\u20131363","journal-title":"Science"},{"key":"1683_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/0-306-46825-5_16","volume":"475","author":"KA Webster","year":"2000","unstructured":"Webster KA, Discher DJ, Hernandez OM, Yamashita K, Bishopric NH (2000) A glycolytic pathway to apoptosis of hypoxic cardiac myocytes. Molecular pathways of increased acid production. Adv Exp Med Biol 475:161\u2013175","journal-title":"Adv Exp Med Biol"},{"key":"1683_CR54","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"GM Acland","year":"2005","unstructured":"Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072\u20131082","journal-title":"Mol Ther"},{"key":"1683_CR55","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1167\/iovs.08-2591","volume":"50","author":"XM Yang","year":"2009","unstructured":"Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK, Wiedemann P (2009) Role of PI3K\/Akt and MEK\/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 50:1873\u20131879","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR56","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000107502","volume":"221","author":"P Zhang","year":"2007","unstructured":"Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, du H (2007) Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 221:411\u2013417","journal-title":"Ophthalmologica"},{"key":"1683_CR57","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1167\/iovs.15-16476","volume":"56","author":"H Andre","year":"2015","unstructured":"Andre H, Tunik S, Aronsson M, Kvanta A (2015) Hypoxia-inducible factor-1alpha is associated with sprouting angiogenesis in the murine laser-induced choroidal neovascularization model. Invest Ophthalmol Vis Sci 56:6591\u20136604","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1683_CR58","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.ophtha.2012.03.043","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Klamerus KJ, Chi-Burris K, Yan E, Paggiarino DA, Rosenblatt I, Aitchison R, Erlich SS, MONET Clinical Study Group (2012) Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study). Ophthalmology 119:1867\u20131873","journal-title":"Ophthalmology"},{"key":"1683_CR59","doi-asserted-by":"publisher","first-page":"14064","DOI":"10.1038\/mtm.2014.64","volume":"2","author":"AL Askou","year":"2015","unstructured":"Askou AL, Aagaard L, Kostic C, Arsenijevic Y, Hollensen AK, Bek T, Jensen TG, Mikkelsen JG, Corydon TJ (2015) Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors. Mol Ther Methods Clin Dev 2:14064","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1683_CR60","first-page":"845","volume":"2","author":"GR Macpherson","year":"2003","unstructured":"Macpherson GR, Ng SS, Forbes SL, Melillo G, Karpova T, McNally J, Conrads TP, Veenstra TD, Martinez A, Cuttitta F, Price DK, Figg WD (2003) Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol Cancer Ther 2:845\u2013854","journal-title":"Mol Cancer Ther"},{"key":"1683_CR61","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.cgt.7700938","volume":"13","author":"RM Tjin Tham Sjin","year":"2006","unstructured":"Tjin Tham Sjin RM, Naspinski J, Birsner AE, Li C, Chan R, Lo KM, Gillies S, Zurakowski D, Folkman J, Samulski J, Javaherian K (2006) Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Ther 13:619\u2013627","journal-title":"Cancer Gene Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1683-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1683-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1683-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:45:29Z","timestamp":1589561129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1683-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1683-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"28 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}